We can certainly look at the availability of data and put together preliminary terms of reference, which we can then share with the committee. Further discussion could clarify different parts of that, and then we'll go over the final terms of reference at that stage. That's a possibility.
As I said earlier, the idea of having a pharmacare program in general is by itself a costing project. Then we need further details in terms of what the committee thinks would be a reasonable kind of structure for that program—whether it is a federal program or a provincial-based program, those kinds of details. Then we can develop better terms of reference on that basis, finalize that with the committee, and start the work.